Fouad Chebib MD FASN

Hereditary Kidney Disease Genetics

Mayo Clinic Nephrologist

4500 San Pablo Rd SAtlantic Beach, FL 32224
Phone+1 904-953-2000

Dr. Chebib is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chebib's full profile Already have an account?

Summary

Dr. Fouad Chebib is a nephrologist in Rochester, MN and is affiliated with multiple hospitals in the area, including Beth Israel Deaconess Medical Center and Mayo Clinic Hospital - Rochester. He received his medical degree from University of Balamand Faculty of Medicine and has been in practice 9 years. He also speaks multiple languages, including Arabic and French. He specializes in hereditary kidney disease genetics and is experienced in nephrology, and polycystic kidney disease.

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Nephrology, 2013 - 2016
St Elizabeth's Medical CenterResidency, Internal Medicine, 2010 - 2013
University of Balamand Faculty of MedicineClass of 2008

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2022 - 2028
MN State Medical License 2013 - 2027
WI State Medical License 2019 - 2027
MA State Medical License 2010 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2014-2017
CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2014-2017
CMS Meaningful Use Stage 2 Certification Mayo Clinic Incorporate Lab Results, Mayo Clinic, 2014-2017

Clinical Trials

Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration Start of enrollment: 2022 Sep 01
COMPLETED
PHASE2

Publications & Presentations

PubMed

Comparison of eGFR based on Serum Cystatin C or Creatinine in Autosomal Dominant Polycystic Kidney Disease.
John Roth, Lisa Vaughan, Ahmad Ghanem, Fadi George Munairdjy Debeh, Austin Kennedy
Kidney360. 2026-07-28
GLUT9b- and ABCG2-mediated collecting duct urate transport uncovers a vasopressin-independent mechanism of renal water reabsorption.
Mohamad Hadla, Jean Marc Mardirossian, Daniel G Bichet, Abdul Hamid Borghol, Georges Abboud
The Journal of Clinical Investigation. 2026-07-15
Emerging Therapies in Autosomal Dominant Polycystic Kidney Disease.
Christopher Y Chen, Mohamad Hadla, Ibrahim Khambati, Sonu Kashyap, Vanessa Westerfield
Kidney360. 2026-07-01

Journal Articles

Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy
Fouad Chebib, MD, American Journal of Kidney Diseases
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan
Ronald D Perrone, Anjay Rastogi, Terry Watnick, Arlene B Chapman, Michal Mrug, Vicente E Torres, Fouad T Chebib, Neera K Dahl, Peter C Harris, Journal of the American Society of Nephrology
Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease
Fouad T Chebib, Vicente E Torres, Journal of the American Society of Nephrology

Press Mentions

Autosomal Dominant Polycystic Kidney Disease: Early Intervention and Lifestyle CrucialMarch 24th, 2025
Visceral Adiposity Improves Prediction of ADPKD Rapid ProgressionSeptember 9th, 2024
Improving Diagnostic Precision with Genetic TestingApril 5th, 2023

Grant Support

Novel role of urinary urate in renal cystogenesis and water regulationMAYO CLINIC JACKSONVILLE2025–2029
Novel role of urinary urate in renal cystogenesis and water regulationMAYO CLINIC JACKSONVILLE2025–2029